Vol 7, No 2 (April 01, 2016): Journal of Gastrointestinal Oncology

Original Article

AKT expression is associated with degree of pathologic response in adenocarcinoma of the esophagus treated with neoadjuvant therapy
Nadia Saeed, Ravi Shridhar, Sarah Hoffe, Khaldoun Almhanna, Kenneth L. Meredith
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:158-165
.
Single centre outcomes from definitive chemo-radiotherapy and single modality radiotherapy for locally advanced oesophageal cancer
Ben Alexander Fulton, Joanna Gray, Alexander McDonald, David McIntosh, Vivienne MacLaren, Aisling Hennessy, Derek Grose
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:166-172
.
Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma
Ellie Chan, Lizette Vila Duckworth, Ahmad Alkhasawneh, Tania Zuluaga Toro, Xiaomin Lu, Kfir Ben-David, Steven J. Hughes, Georgios Rossidis, Robert Zlotecki, Judith Lightsey, Karen C. Daily, Long Dang, Carmen J. Allegra, Brent King, Thomas J. George Jr
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:173-180
.
Drain amylase aids detection of anastomotic leak after esophagectomy
Erin H. Baker, Joshua S. Hill, Mark K. Reames, James Symanowski, Susie C. Hurley, Jonathan C. Salo
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:181-188
.
Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients
Jalal Hyder, Drexell Hunter Boggs, Andrew Hanna, Mohan Suntharalingam, Michael David Chuong
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:189-195
.
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen
Michael J. McNamara, Lisa A. Rybicki, Davendra Sohal, Daniela S. Allende, Gregory M. M. Videtic, Cristina P. Rodriguez, Kevin L. Stephans, Sudish C. Murthy, Siva Raja, Daniel Raymond, Denise I. Ives, Joanna W. Bodmann, David J. Adelstein
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:196-205
.
Perioperative outcomes associated with robotic Ivor Lewis esophagectomy in patient’s undergoing neoadjuvant chemoradiotherapy
Ravi Shridhar, Andrea M. Abbott, Matthew Doepker, Sarah E. Hoffe, Khaldoun Almhanna, Kenneth L. Meredith
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:206-212
.
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma
Mirko D’Onofrio, Emilio Barbi, Roberto Girelli, Paolo Tinazzi Martini, Riccardo De Robertis, Valentina Ciaravino, Roberto Salvia, Giovanni Butturini, Isabella Frigerio, Teresa Milazzo, Stefano Crosara, Salvatore Paiella, Paolo Pederzoli, Claudio Bassi
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:213-220
.
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer
Michael D. Chuong, Jessica M. Frakes, Nicholas Figura, Sarah E. Hoffe, Ravi Shridhar, Eric A. Mellon, Pamela J. Hodul, Mokenge P. Malafa, Gregory M. Springett, Barbara A. Centeno
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:221-227
.
Patient and caregiver awareness of pancreatic cancer treatments and clinical trials
Anitra Engebretson, Lynn Matrisian, Cara Thompson
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:228-233
.
Phase II trial of capecitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma
Werner Scheithauer, Gabriela Kornek, Gerald Prager, Nadja Stranzl, Friedrich Laengle, Martin Schindl, Josef Friedl, Julia Klech, Sabine Roethlin, Christoph Zielinski
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:234-238
.
Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy
Arsen Osipov, Jason Naziri, Andrew Hendifar, Deepti Dhall, Joanne K. Rutgers, Shefali Chopra, Quanlin Li, Mourad Tighiouart, Alagappan Annamalai, Nicholas N. Nissen, Richard Tuli
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:239-247
.
Neoadjuvant chemoradiation followed by orthotopic liver transplantation in cholangiocarcinomas: the emory experience
Edward M. Marchan, Jerome C. Landry
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:248-254
.
Percutaneous “Y” biliary stent placement in palliative treatment of type 4 malignant hilar stricture
Fabio Corvino, Luca Centore, Emilio Soreca, Antonio Corvino, Vincenzo Farbo, Alfonso Bencivenga
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:255-261
.
Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib—an Indian series
Vishwas D. Pai, Jean L. Demenezes, Prachi S. Patil, Avanish P. Saklani
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:262-268
.
Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy
Nicole D’Emic, Alexander Engelman, Jason Molitoris, Alexandra Hanlon, Navesh K. Sharma, Fred M. Moeslein, Michael D. Chuong
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:269-277
.

Short Communication

Expression of SPARC like protein 1 (SPARCL1), extracellular matrix-associated protein is down regulated in gastric adenocarcinoma
Aniruddha Jakharia, Biswajyoti Borkakoty, Sujay Singh
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:278-283
.

Review Article

Metastatic colorectal cancer presenting with bone marrow metastasis: a case series and review of literature
Rita Assi, Deborah Mukherji, Ali Haydar, Maya Saroufim, Sally Temraz, Ali Shamseddine
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:284-297
.
Management of the right hepatic artery in pancreaticoduodenectomy: a systematic review
Mehdi El Amrani, François-René Pruvot, Stéphanie Truant
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:298-305
.

Case Report

Widespread osteoblastic metastases and marked elevation of CA19-9 as a presentation of signet ring cell gastric carcinoma
Yuval Link, Asaf Romano, Jacob Bejar, Elad Schiff, Yaniv Dotan
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:E1-E5
.
Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted therapy with backbone chemotherapy
Benny Johnson, Ari Vanderwalde, Nader Javadi, Rebecca Feldman, Sandeep Bobby Reddy
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:E6-E12
.
Recognizing the distinct cytomorphologic features of solid pseudopapillary neoplasm of the pancreas
Saadiya Haque, Robin Dietz, Mia C. N. Perez
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:E13-E16
.
Use of molecular studies for treatment of metastatic pleomorphic large cell pancreatic cancers—a novel strategy
Parikshit Padhi, Arshjyot Narula, Anna Balog, Antonios Christou
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:E17-E21
.
Genomic profiling of high-grade large-cell neuroendocrine carcinoma of the colon
William A. Hammond, Jennifer A. Crozier, Raouf E. Nakhleh, Kabir Mody
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:E22-E24
.
Metastatic colon cancer from extrahepatic cholangiocarcinoma presenting as painless jaundice: case report and literature review
Benjamin W. Vabi, Jeffrey Carter, Rong Rong, Minhua Wang, James G. Corasanti, John F. Gibbs
Journal of Gastrointestinal Oncology  
2016;
7
(2)
:E25-E30
.